December 19, 2025 12:32 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Worst is over,’ says IndiGo CEO after flight chaos; staff told to ignore speculation | Chaos at Hyderabad's Lulu Mall! Nidhhi Agerwal swarmed by fans, police register case | TCS bets big on AI, shares spike as company reveals ambitious plan | Delhi goes into emergency mode! Work from home, vehicle bans as AQI hits ‘severe’ | Massive fire guts shanties near Eco Park in Kolkata; no casualties | Indian Visa Application Centre in Dhaka shuts down early amid rising security concerns | Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell | ‘Won’t apologise’: Prithviraj Chavan stands firm on controversial Operation Sindoor remark despite backlash | India summons Bangladesh High Commissioner after provocative 'seven sisters' remark | Amazon eyes $10 billion investment in OpenAI — a gamechanger for AI industry!
COVID-19
Image Credit: UNI

India reports 60,471 new COVID-19 cases, 2,726 deaths in 24 hours

| @indiablooms | Jun 15, 2021, at 04:18 pm

New Delhi/IBNS: India on Tuesday reported less than one lakh new COVID-19 cases for the eighth consecutive days while the toll in the last 24 hours remained under the three-thousand-mark.

In the last 24 hours, the Asian country with a huge population added 60,471 new infections pushing the overall tally to 29,570,881.

With 2,726 deaths apparently linked to the virus caused in the same time span, the COVID-19 toll has peaked to 3,77,031.

The recovery figure has further improved to 2,82,80,472 with 1,17,525 COVID-19 patients testing negative for the virus.

Meanwhile, the All India Institute of Medical Sciences (AIIMS), New Delhi will begin the selection process of children in the age group of 6-12 years for the clinical trials of Bharat Biotech's Covaxin on Tuesday, said Dr Sanjay Rai, professor at the Centre for Community Medicine at AIIMS Delhi, said a media report.

After the recruitment of children in the age group is done, the process for clinical trials for children between 2 to 6 years of age will be started, the report added.

The screening for clinical trials in the age group of 12 to 18 is already completed and they have been administered with a single dose of the vaccine, it said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.